logo
Plus   Neg
Share
Email

Rainmaker Systems Reports Inducement Grant Under NASDAQ Listing Rule

Rainmaker Systems Inc. (RMKR) announced that the Compensation Committee of Rainmaker's Board of Directors granted an inducement award to Donald Massaro in connection with his entering into employment as Rainmaker's President and Chief Executive Officer.

On December 13, 2012, Rainmaker previously announced the hiring of Massaro, with his employment beginning on December 11, 2012.

Massaro's inducement awards, granted under Rainmaker's 2012 Inducement Equity Incentive Plan adopted by Rainmaker's Board of Directors on December 21, 2012, consist of (1) a grant of 500,000 restricted shares of common stock which will vest 1/16th quarterly over a four year term, (2) an option to purchase 500,000 shares of common stock which will vest 1/16th quarterly over a four year term and (3) a grant of 250,000 restricted shares of common stock which will vest in a single installment on March 31, 2013.

The grant of 250,000 restricted shares vesting on March 31, 2013 was negotiated by Massaro as part of his initial compensation, as Massaro requested stock compensation in lieu of cash compensation for a specified period due to his confidence in Rainmaker's potential future stock price appreciation.

The Compensation Committee of Rainmaker's Board of Directors granted the awards on December 27, 2012 as inducements material to Massaro entering into employment with Rainmaker in accordance with NASDAQ Listing Rule 5635(c)(4).

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT